These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3218975)

  • 41. Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Kline I; Woodman RJ; Gang M; Cysyk RL; Venditti JM
    Cancer Chemother Rep; 1973; 57(3):291-8. PubMed ID: 4751255
    [No Abstract]   [Full Text] [Related]  

  • 42. Cytostatic action of two nitrosoureas derived from cysteamine.
    Bourut C; Chenu E; Godenèche D; Madelmont JC; Maral R; Mathé G; Meyniel G
    Br J Pharmacol; 1986 Nov; 89(3):539-46. PubMed ID: 3801787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP; Schein PS
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract]   [Full Text] [Related]  

  • 44. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
    Lin TS; Fischer PH; Marsh JC; Prusoff WH
    Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antitumor activity of a water-insoluble compound entrapped in liposomes on L1210 leukemia in mice.
    Brassinne C; Atassi G; Frühling J; Penasse W; Coune A; Hildebrand J; Ruysschaert JM; Laduron C
    J Natl Cancer Inst; 1983 Jun; 70(6):1081-6. PubMed ID: 6574278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel bifunctional anthracycline and nitrosourea chemotherapy for human bladder cancer: analysis in a preclinical survival model.
    Glaves D; Murray MK; Raghavan D
    Clin Cancer Res; 1996 Aug; 2(8):1315-9. PubMed ID: 9816302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pyrrolo(3,2-d)pyrimidines as potential antitumor agents].
    Kravchenko AI; Chernov VA; Shcherbakova LI; Filitis LN; Pershin GN
    Farmakol Toksikol; 1979; 42(6):659-65. PubMed ID: 499477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early history and development of the nitrosoureas.
    Schepartz SA
    Cancer Treat Rep; 1976 Jun; 60(6):647-9. PubMed ID: 782693
    [No Abstract]   [Full Text] [Related]  

  • 50. Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia.
    Hansch C; Leo A; Schmidt C; Jow PY; Montgomery JA
    J Med Chem; 1980 Oct; 23(10):1095-101. PubMed ID: 7420354
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Dynamics of the chromosomal damages to Ehrlich ascitic cancer and bone marrow cells of mice by the antitumor preparation dimetinur].
    Fomina MM; Bogoslovskaia EP; Konradov AA; Ostrovskaia LA
    Eksp Onkol; 1986; 8(3):70-4. PubMed ID: 3720644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-activity relationships: nitrosoureas.
    Johnston TP
    Cancer Chemother Rep 3; 1972 May; 3(1):50-1. PubMed ID: 5065660
    [No Abstract]   [Full Text] [Related]  

  • 53. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
    Schmid FA; Otter GM; Mehta BM
    Cancer Res; 1985 Jan; 45(1):40-4. PubMed ID: 3965147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cancerostatic effect of some fluorenone azomethines tested against leukemia L 1210 (author's transl)].
    Jungstand W; Gutsche W; Wohlrabe K; Schulze W
    Arch Geschwulstforsch; 1979; 49(1):15-7. PubMed ID: 444028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemistry and structure-activity studies of the nitrosoureas.
    Montgomery JA
    Cancer Treat Rep; 1976 Jun; 60(6):651-64. PubMed ID: 954007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and preliminary in vitro evaluation of antitumor nitrosoureido cholesterol derivatives.
    Elkihel L; Gelin M; Letourneux Y
    Arzneimittelforschung; 1995 Feb; 45(2):190-4. PubMed ID: 7710447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of DONU, a new derivative of water-soluble nitrosourea, on human tumors serially transplanted into nude mice].
    Asanuma F; Kubota T; Hanatani Y; Tsuyuki K; Nakada M; Ishibiki K; Abe O
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2035-43. PubMed ID: 7169576
    [No Abstract]   [Full Text] [Related]  

  • 58. [Chemotherapeutic characterization of new nitrosourea compounds].
    Zeller WJ; Berger MR; Eisenbrand G; Petru E
    Arch Geschwulstforsch; 1988; 58(3):137-49. PubMed ID: 3415433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of a new nitrosourea derivative, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea with various antitumor agents with respect to therapeutic ratios in L1210 leukemia systems.
    Fujimoto S; Ogawa M
    J Pharmacobiodyn; 1987 Jul; 10(7):341-5. PubMed ID: 3694427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellular response to treatment with 4-(3-(2-chloroethyl)-3-nitrosoureido)-cis-cyclohexanecarboxylic acid, a water-soluble nitrosourea derivative.
    Drewinko B; Green C; Loo TL
    Cancer Treat Rep; 1977 Nov; 61(8):1513-8. PubMed ID: 922754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.